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A high prevalence of abnormal nutrition parameters found in predialysis end-
stage kidney disease: is it a result of uremia or poor eating habits? 
Abstract 
Objective To describe the baseline nutritional characteristics of a cohort of end-stage kidney disease 
(ESKD) patients attending a pre-dialysis clinic. Setting Outpatient clinic of a metropolitan tertiary teaching 
hospital in Sydney, Australia. Subjects All ESKD patients attending the multidisciplinary pre-dialysis 
assessment clinic between April 2002 and March 2008. Methods Retrospective analysis of data extracted 
from the routine initial nutrition assessment records. These included anthropometric and biochemical 
measures, Subjective Global Assessment, appetite score, presence of symptoms, dietary energy, protein, 
and other macro- and micronutrient intakes. Results Of the 210 patients assessed, 60.5% were male; 
mean age was 65.7 ± 13.6 years with a mean glomerular filtration rate of 17.3 ± 6.5 mL/min/1.73 m2; 
17.1% and 62.4% were underweight (body mass index /m2) and overweight or obese (BMI ≥26 kg/m2), 
respectively; 40.5% were rated as malnourished (Subjective Global Assessment scores B and C) with 
19.0% overweight/obese and malnourished. Energy and protein intakes correlated positively with 
glomerular filtration rate, with r = 0.17, P = .01, and r = 0.29, P < .0001 respectively. Mean energy and 
protein intakes were 23.7 ± 6.7 kcal/kg IBW/day and 1.18 ± 0.42 g/kg IBW/day, with 62.6% and 13.1% not 
meeting the recommended intake, respectively. The positive predictive values (95%CI) of self-rated 
appetite score for energy and protein were 0.41 (0.36-0.45) and 0.92 (0.88-0.95), respectively, indicating 
subjective rating of a good appetite was associated with adequate protein but not energy intake. Fifty-one 
percent of the patients experienced the symptoms, whereas 17.5% of the patients self-imposed a dietary 
regimen inappropriately due to beliefs on dietary needs in ESKD. Suboptimal nutrient intakes were 
observed, including vitamin B2 (41.2%), vitamin E (61.8%), folate (67.6.2%), vitamin D (100.0%), and zinc 
(64.2%). Conclusion Patients presented to the pre-dialysis assessment clinic with abnormal nutrition 
parameters associated with decreased renal function, symptoms burden, and poor dietary intake. This 
clinic may provide an opportunity to optimize the nutritional status of ESKD patients in the pre-dialysis 
period. 
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Objective: To describe the baseline nutritional characteristics of a cohort of end stage kidney 
disease (ESKD) patients attending a pre-dialysis clinic. 
 




Subjects: All ESKD patients attending the multidisciplinary pre-dialysis assessment clinic 
between April 2002 and March 2008. 
 
Methods:  Retrospective  analysis  of  data  extracted  from  the  routine  initial  nutrition 
assessment records. These included anthropometric and biochemical measures, subjective 
global assessment (SGA), appetite score, presence of symptoms, dietary energy, protein, 
other macro- and micronutrient intakes. 
 
Results: Of the 210 patients assessed, 60.5% were male; mean age was 65.7±13.6 years with 
a mean glomerular filtration rate (GFR) of 17.3±6.5 mL/min/1.73m2. 17.1% and 62.4% were 
underweight  (BMI <23  kg/m2) and  overweight  or obese (BMI ≥26  kg/m2) respectively. 
40.5% were rated as malnourished (SGA score B and C) with 19.0% overweight/obese and 
malnourished. Energy and protein intakes correlated positively with GFR, being r =0.17, P 
=0.01 and r =0.29, P <0.0001 respectively. Mean energy and protein intakes were 23.7±6.7 
kcal/kg IBW/d and 1.18±0.42 g/kg IBW/d, with 62.6% and 13.1% not meeting the 
recommended intake respectively. The positive predictive values (95%CI) of self-rated 
appetite score for energy and protein were 0.41 (0.36-0.45) and 0.92 (0.88-0.95) respectively 
indicating subjective rating of a good appetite was associated with adequate protein but not 
energy intake. 51.0% of patients experienced symptoms, while 17.5% of patients self- 
imposed a dietary regimen inappropriately due to beliefs on dietary needs in ESKD. Sub- 
optimal nutrient intakes were observed including vitamin B2 (41.2%), vitamin E (61.8%), 
folate (67.6.2%), vitamin D (100.0%) and zinc (64.2%). 
11 
Conclusion: Patients presented to the pre-dialysis assessment clinic with abnormal nutrition 
parameters associated with decreased renal function, symptoms burden, and poor dietary 
intake. This clinic may provide an opportunity to optimise nutritional status of ESKD patients 






Poor nutritional status and presence of protein energy wasting (PEW) at the start of dialysis 
are associated with morbidity, mortality and hospitalisation1-6. Thus, timely nutrition 
intervention is important in end stage kidney disease (ESKD) well before dialysis is required. 
Indeed, nutritional status deteriorates during the course of decline of renal function,7, 8 and the 
presence of nutrition abnormalities is known to associate with adverse outcomes, including 
accelerated atherosclerosis,9 mortality and hospitalisation.10 Cross-sectional7, 11-14 and 
longitudinal8,  15   studies have established that  spontaneous  intakes  of protein  and  energy 
decline as GFR falls. Furthermore, poor appetite, commonly found in dialysis-dependent 
ESKD patients, has been associated with mortality, morbidity and hospitalisation.16, 17 On the 
other hand, over-nutrition, such as the presence of obesity at the start of dialysis, is associated 
with high mortality risk.5 However, other researchers found the protective effect of obesity in 
  patients with ESKD, which is known as the “obesity paradox”.18   All these highlight the 
 
complex and heterogeneous nutritional abnormalities of patients with ESKD before and after 
 
starting dialysis.  Historically, nutritional intake studies in pre-dialysis ESKD patients have 
been mainly focused on energy and protein intake. Other nutrients, food patterns or intake of 
specific foods such as fruit and vegetables have received relatively little attention. In order to 
establish sound clinical practice, it is necessary to gain a broader insight into nutritional 
parameters, including dietary intake of energy, protein and other nutrients, information on 
food patterns, the presence of symptoms and clinical indicators of the nutritional status of 
these patients. Therefore, our study was differing to previous studies and encompassed many 
of these parameters in one study. It is also worth noting the growing number of elderly 
patients entering the advanced renal care program19  with additional age-related nutritional 
 
health concerns, such as osteoporosis and sarcopenia. The aim of this study was to describe 
13 
the  baseline  demographic,  clinical  and  nutritional  characteristics  of  a  cohort  of  ESKD 
 








This retrospective study examined clinical and initial routine nutrition assessment records of 
all patients attending an outpatient pre-dialysis assessment clinic established in April 2002 
through March 2008. Patients referred by renal physicians to this multidisciplinary clinic 
were predominantly in CKD stages 4 and 5 (GFR <30 mL/min/1.73m2) and were assessed by 
the clinical nurse consultant, pharmacist, social worker and dietitian (MC). Exclusion criteria 
were those patients who missed the dietitian assessment, incomplete or unreliable assessment 
data, or late referral to the pre-dialysis assessment team during acute hospital admission, with 








From  hospital  records,  data  collected  including  age,  gender,  race,  smoking  habits  and 
presence of co-morbidities, e.g., coronary artery disease (CAD), diabetes mellitus (DM), 








Anthropometric measures performed by the dietitian were height (m); oedema-free body 
weight (kg); body mass index (BMI weight  height2, [kg/m2]) and weight history; mid-arm 
circumference (MAC) and triceps skinfold (TSF). Mid-arm muscle circumference (MAMC) 
was calculated using the following formula: MAMC (cm) = MAC (cm) – 0.314 x TSF (mm). 
The clinical practice guidelines20 define a healthy range for BMI of 22–26 kg/m2; therefore 
BMI ≥26 kg/m2 was treated as overweight. Prevalence of renal-specific BMI categories20, 21 
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were also examined with undernourished, ideal range, overweight and obese defined as BMI 
 
<23, 23–26, 26–30 and ≥30 kg/m2 respectively. Muscle wasting was classified as MAMC 
 
>10% and <50th  percentile of the reference standard for age and gender.21, 22  Blood results 
closest to and within 2 months of the clinic were extracted from clinical notes; these included 
serum-albumin (s-albumin) and serum creatinine to calculate GFR using the Cockcroft-Gault 
equation.23 Approximately 50% of the blood tests were analysed in private providers instead 
of the hospital-based laboratory; thus, different analytical methods used for s-albumin with 
different  reference  ranges.  Therefore, for  the  s-albumin  levels,  both  actual  figures  plus 
whether they were below or within reference ranges were recorded for analysis. 
 
Subjective global Assessment (SGA) 
 
The renal dietitian(s) (MC) performed the subjective global assessment (SGA),24, 25 which 
categorised patients as A = well nourished, B = mild-moderately and C = severely 
malnourished, based on the patient’s medical history and physical examination. The 
prevalence of combined malnutrition (SGA score = B and C) and BMI (<26 kg/m2 vs. 26 




Appetite, Symptoms and Intake Assessment 
 
Patients’ subjective rating of appetite was assessed using the Appetite and Diet Assessment 
Tool (ADAT) with a 5-point Likert scale:26 (1) very good, (2) good, (3) fair, (4) poor and (5) 
very poor. For easy comparison, appetite scores were combined into “good appetite” (very 
good and good) versus “reduced appetite” (fair, poor and very poor). The presence of other 
nutrition-related symptoms were also assessed, e.g., nausea and taste aversion. A “typical 
day’s dietary intake” was assessed by the dietitian using a structured diet history or diet 
interview method,27-30 taking into account food frequency and weekend variations. Food 
pictures and models, household metric measuring cup and spoons were used to assist serving 
size estimation. The structured diet history method is considered to be a feasible method for 
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the initial outpatient clinic visit compared with the 3-day food record used in other studies.12, 
13 Urinary nitrogen excretion was not routinely collected in our unit, so we were not able to 
measure nitrogen appearance to estimate protein intake as in previous studies.11, 15 Dietary 
intake data were analysed using a computerised nutrient analyses program (FoodWorks 
Professional Model 2009, Xyris, Brisbane, Australia) to estimate energy intake (EI), dietary 
protein intake (DPI) and intake of other nutrients. EI and DPI intakes were expressed in kcal 
 
and  g  per  kg  IBW  (ideal  body  weight)  per  day  or  kcal/kg  IBW/d  and  g/Kg  IBW/d 
respectively. For overweight patients, adjusted body weight (adjusted BW) was used instead 
of IBW; adjusted BW = IBW + [(oedema-free BW – IBW) x 0.25].20, 31 
 
To evaluate possible underreporting, the ratio of EI to resting energy expenditure (REE) was 
calculated using the Schofield equation.32 An EI:REE ratio less than 1.27 (known as the 
Goldberg cut-off value)33, 34 may indicate possible underreporting of EI; if an EI:REE <1.27 
was present, other explanations of low EI were also reviewed, e.g., presence of symptoms 
and physical inactivity defined as physical activity level (PAL) equal or less than 1.5.35, 36 In 
the current study, PAL was rated according to patients’ description of their typical daily 
physical activity including any participation in leisure or structured exercise programs. 
Average daily consumptions of fruit, vegetable and fish were surveyed and compared to the 
Australian Guide of Health Eating recommendations of “two fruit and five vegetables”37 and 
the American Heart Association’s “Healthy diet goals”38  of at least two servings of fish per 
 






All statistical analyses were performed using the statistical software IBM© SPSS©  Statistics 
version 20. Continuous variables were expressed as mean ± standard deviation for normally 
distributed data and comparisons between groups were performed using unpaired sample t- 
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tests. Categorical variables were compared using the 2 test. Correlations between GFR and 
dietary energy and protein intakes were estimated using Pearson correlation coefficients. 
Analysis of variance (ANOVA) was used to compare the parameters among three to four 
categories. The positive predictive values (PPV) of appetite score for adequate energy (≥25 
g/kg IBW/d)21  and protein intake (≥0.75 g/kg IBW/d)20  were assessed using the two-way 
contingency analysis table.39 P values <0.05 were taken as showing a statistically significant 
 
difference. This study was approved by the ethics committee of the South Eastern Sydney 






Two hundred and twenty-seven patients attended the pre-dialysis assessment clinic during the 
study period. Two hundred and ten patients were assessed by the dietitian with 206 reliable 
dietary assessment records available for computerised nutrient analysis. Table 1 summarises 
the demographic and clinical characteristics of these patients. Patients were predominantly in 
CKD stages 4 (56.5%) and 5 (38.2%) with a mean GFR of 17.3±6.5 mL/min/1.73m2. The 
main cause of ESKD was diabetic nephropathy (24.2%). 
 
 
A high prevalence of nutrition abnormalities was found in this cohort. As shown in Table 2. 
the prevalence of malnutrition (SGA = B and C) was 40.5% and 19.0% of patients were 
overweight and malnourished. Within the malnourished group, 47.1% of patients were 
overweight/obese, and within the overweight/obese group, 30.5% of patients were rated as 
malnourished. Unintentional loss of body weight was not uncommon in this population and 
37.3% of patient had s-albumin levels below the reference range. 28.4% of patients were 
classified as muscle-wasted according to the PEW criteria.21 
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Approximately  14.8%  of  patients  reported  having  previous  contact  with  dietitian(s)  for 
various diet interventions, but rarely (<5%) related to CKD stage 4 or 5 dietary management 
with  structured  care  and  regular  follow-up.  Therefore,  all  of  these  dietary  data  were 
considered as spontaneous intake. As expected, energy and protein intake correlated 
significantly with GFR: r =0.17, P =0.01 (Figure 1) and r =0.29, P <0.0001 (Figure 2) 
respectively. However, as shown in Table 3, energy and nutrient intake and food habits 
varied vastly among individuals. Mean EI was low at 23.7±6.7 kcal/kg IBW/d with 87.9% of 
patients having an EI below the recommended ~35 kcal/kg IBW/d for <60 years of age and 
~30 kcal/d for >60 years of age.20, 40 According to the PEW classification21 of no less than 25 
 
kcal/kg IBW/d, 62.6% of patients had insufficient EI. 76.2% of patients had an EI:REE ratio 
(Goldberg cut-off) <1.27 and 41.7% had an EI below REE (ratio <1.00). However, further 
analysis indicated that these patients, when compared to those with an EI:REE ratio >1.27, 
had significantly higher prevalence of malnutrition (45.2% vs. 26.5%, 2=5.4, P =0.02). 
Furthermore, the majority of patients (88.3%) were very inactive, with a PAL of 1.5 
(sedentary) or less (very sedentary or bed-/chair-ridden), and 22.8% reported a reduced 
physical function under the SGA sub-category of physical function rating. The mean protein 
intake was 1.18±0.42 g/kg IBW/d with 13.1% below and 61.2% above the ideal range of 
0.75–1.00 g/kg IBW/d.20 4.9% of patients consumed less than the 0.6 g/kg IBW/d level 
 




The 5-point Likert scale appetite score was found useful in ranking and correlated with the 
incremental changes of both EI and DPI; EI was 25.4±6.0, 24.2±6.8, 22.0±6.8, 19.4±6.2 and 
14.9±1.8 kcal/kg IBW/d (P =0.002) respectively (Figure 3); and the same applied for DPI of 
 
1.32±0.36, 1.17±0.45, 1.13±0.44, 0.86±0.25 and 0.57±0.18 g/kg IBW/d (P =0.001) (Figure 4) 
For the combined scores of “good” and “reduced” appetite for protein and energy intakes, the 
rating showed statistical difference between the EI and DPI of 24.7±6.5 vs. 21.2±6.7 kcal/ kg 
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IBW/d (P =0.001) and 1.24±0.42 vs. 1.06±0.42g/kg IBW/d (P =0.006) respectively. The PPV 
(95%CI) of appetite rating for energy and protein were 0.41 (0.36-0.45) and 0.92 (0.88-0.95) 
respectively. These reflect 41% of patients rated a “good appetite” and consumed adequate 
energy, while the remainder (59%) rated “good appetite” but did not consume adequate 
energy.  The  PPV  for  DPI  was  0.92  reflecting  the  appetite  rating  was  satisfactory  in 
identifying adequate protein intake. 
 
38.1% of patients reported the presence of symptoms including reduced appetite, and/or 
nausea and/or taste aversion. However, with further prompting during the in-depth dietary 
intake assessment by the dietitian, a total of 51.0% of patients and/or their carers disclosed 
“problems” with eating of various degrees. The mean intakes of energy and protein between 
the “no symptom” versus “presence of symptom” groups were 25.7±6.3 vs. 21.8±6.3 kcal/kg 
IBW/d (P <0.0001) and 1.33±0.42 vs. 1.05±0.39 g/kg IBW/d (P <0.0001) respectively. 
 
Furthermore, during the in-depth dietary intake assessment, 17.1% of patients were found to 
impose inappropriate dietary regimens due to misconceptions of nutrition knowledge for 
ESKD. Examples of inappropriate restriction (15.7%) included: severe reduction of total fat 
and sugar intake being mistaken for good eating habits or for lipid-lowering or weight 
management; limiting fruit and vegetables to control serum potassium when it was not 
required; and/or severe limiting of protein foods, especially red meat, in an attempt to manage 
kidney disease. Inappropriate excess food intake (1.4%) was found in diabetic patients to 
avoid hypoglycaemia (“hypos”) and the use of a high protein-low carbohydrate diet for 
controlling weight. The sources of confusion mainly came from advice from relatives or 
friends,  other  health  care  practitioners  and  from  misinterpreting  information  from  the 
Internet. The inappropriate intake group, when compared with the spontaneous intake group, 
had significant reduced mean intake of energy and protein of 21.2±4.0 vs. 24.2±7.1 kcal/kg 
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IBW/d (P =0.02) and 1.02±0.33 vs. 1.22±0.44 g/kg IBW/d (P =0.01) respectively. The “▲” 
symbol shown in Figures 1 and 2 represents the inappropriate energy and protein intakes 
among all patients, and the majority of self-imposed dietary restrictions had led to suboptimal 
intake. Within this group of 33 patients, 54.5% of those were rated as malnourished, mainly 
as a consequence of self-induced poor intake. 
 
Regarding the other nutrient intakes (Table 3), the mean intakes of folate, vitamin D, vitamin 
 
E, calcium, iodine, magnesium, zinc and dietary fibre were below the RDI.36  41.3% and 
89.2% of patients did not consume the recommended two serves of fruit and five serves of 
vegetables each day. 60.8% of patients consumed less than the recommended servings of fish 
(equivalent to 30 g/day). Many of these patients reported inadequate fruit, vegetables and fish 
 
intake as their usual food habits. However the prevalence was not available for all patients 
due to the retrospective nature of the study. 
Patients in later stages of CKD or lower GFR levels were generally older, had lower protein 
intake, lower BMI and other anthropometric measures (Table 5).  The prevalence of 
 
malnutrition and presence of symptoms increased as GFR decreased and were high in all 
groups. No statistical difference was observed across all groups for the mean EI (P 




Among the three age groups: <65, 65–75 and >75 years (Table 6), anthropometric measures 
such as BMI and MAMC (% standard) were lower in the >75  year age group, but no 
statistical  difference  was  found  in  the  TSF  (%  standard)  among  the  three  groups.  This 
reflected that older patients were more likely to be muscle-depleted, but not necessarily lower 
in their fat stores. No statistical difference was observed for dietary protein and energy 
intakes between the 65–75 vs. ≥75 year age groups, but these were significantly lower than 







The main goals of nutrition management in ESKD are to maintain optimal nutritional status, 
to preserve renal function and to achieve therapeutic targets. Findings of the current study 
indicated that patients presented to the pre-dialysis assessment clinic with high prevalence of 
suboptimal intake, nutrition abnormalities, malnutrition and parameters indicative of poor 
nutritional health. The magnitude of these nutritional issues increased as renal function 
deteriorated. 
 
Our cohort was more advanced in age (65.7±13.6 years) and stages of CKD (mean GFR 
 
~17.3±6.5) compared with the majority of previous studies (mean age of 50–55 years and 
GFR of 20–55 mL/min/1.73m2) except in one study. In line with the findings in the 
literature,7, 12, 13 nutritional status deteriorated with decreased renal function, in particular 
once GFR levels fell below 20 mL/min/1.73m2. GFR levels at which symptoms emerged 
varied enormously among individuals; the prevalence increased dramatically once GFR fell 
below 15 mL/min/1.73m2. However, we also found 45% of patients with a GFR of >20 
mL/min/1.73m2 experienced symptoms. Presence of symptoms was found in a patient with 
a GFR as early as 41.6 mL/min/1.73m2, while some patients appeared fairly symptom- free 
with a GFR below 10 mL/min/1.73m2. 
 
Consistent with the literature,7, 8, 11-13, 15, 42 spontaneous DPI was lower with lower GFR, with 
an average DPI of 1.18±0.42 g/kg IWB/d. The mean EI was comparable to that reported in 
the literature,12-14, 42, 43 with a significant number of our patients consuming less energy than 
recommended.20, 21, 41  Despite 76.2% of patients having an EI:REE ratio of less than 1.27 – 
the Goldberg cut-off indicating possible underreporting as described by other researchers,34, 42 
the suboptimal intake of our patients could largely be explained by the high prevalence of 
malnutrition  accompanied  by  unintentional  weight  loss,  muscle  wasting,  high  symptom 
burden and physical inactivity. These observations were supported by a previous finding44 
that lean body mass (LBM), bone mineral content and basal EE were lower in patients with 
21 
CKD (mean GFR 23.9±2.6 mL/min/1.73m2) compared with pair-matched controls. This 
observation is further supported by a study that showed the commonly-used REE equations 
were found to over-predict REE in CKD patients.45 Since no inflammatory marker, such as C 
reactive protein (CRP), was measured, the inflammation state of our patients was not known 
to interpret its effect on appetite, EI, REE, nutritional status, or its relationship with co- 
morbidities. Unfortunately, from observation, many of our patients mistakenly perceived a 
low EI was an acceptable effect of aging on lower food intake and physical inactivity, and 
failed to recognise the presence of uraemic symptoms. Even more confusing was that in the 
overweight/obese patients, a reduced intake could be a combination of intentional limiting of 
EI to control weight and unintentional reduction due to uraemia. Malnutrition within the 
overweight/obese group was prevalent at 30.5%; this observation could not be ignored as 
being overweight and malnourished at the start of dialysis has been associated with high 
mortality risk.6 
 
An optimal level of protein in the diet of 0.75–1.00 g/kg IBW/d20  is recommended for this 
population  to  control  uraemia  and  symptoms;46,   47    most  importantly,  this  must  be 
accompanied by an adequate intake of energy to maintain nitrogen balance.20, 40, 47 37.9% of 
patients  met  the  protein  requirements  but  the  majority  (90.6%)  did  not  meet  energy 
requirements. On the other hand, 43.7% of patients consumed protein above this level but EI 
was poor. The undesirable combination of excess protein and low energy intakes has been 
associated with adverse parameters in patients with advanced CKD.48, 49 
 
It  appears  that  the  significant  protein  intake  reduction  occurred  after  GFR  fell  below 
 
20 mL/min/1.73m2; this is in line with the findings that normalised protein catabolic rate 
(nPCR) dropped when creatinine clearance (CrCl) fell below 25 mL/min8 and ended in a 
dramatic decline when CrCl reached 15 mL/min.15  It is generally accepted that uraemia 
causes spontaneous reduction or self-limiting of DPI; however in our cohort, despite a total 
reduction of total energy or food intake, protein intake remained excessive in 61.2% of 
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patients, even those with reported reduced appetite and symptoms. This could partly be 
explained by the high habitual protein intake of the average Australian adult as reported in 
the national dietary survey, almost twice the RDI level of 0.75 g/kg/d.50, 51 Again, excess 
protein intake has been associated with more rapid renal function deterioration and mortality 
even in early CKD,52, 53 and increased uraemic toxins.46 Therefore, timely intervention to 
optimise dietary intake is recommended. 
 
 
Both the ADAT 5-point Likert scale appetite score and the combined “good appetite” vs. 
“reduced appetite” score were found to be useful in ranking energy and protein intake, and 
were useful in identifying adequate protein intake but not EI. A possible explanation is that 
the average Australian consumes more protein than recommended discussed as above ,50, 51 so 
a “reduced” protein intake in uraemic patients could still be adequate or in excess, but this is 
not the same for total EI. These findings suggested subjective rating of appetite is insufficient 
to reflect neither actual nor adequate dietary intake in a population with a gradual onset of 
symptoms; thus structured interview and skilled diet history-taking should form an essential 
part of nutritional assessment. To our knowledge, no previous study has analysed the PPVs of 
appetite score and dietary intakes of energy and protein in patients with pre-dialysis ESKD. 
 
Abnormal vitamin and mineral status, including retention and deficiency, are common in 
patients  with  ESKD,54,   55   and  are  associated  with  increased  morbidity  and  mortality. 
Examples include low vitamin D levels and increased CVD risk,56-58 folic acid deficiency 
relating to anaemia,59  elevated homocysteine and increased CVD risk,59  and iron deficiency 
relating to resistance to recombinant erythropoietin (rHuEPO) to correct anaemia.60  Despite 
the  “mean”  intake  of  many  nutrients  appearing  satisfactory,  a  significant  percentage  of 
patients did not meet the RDI of these nutrients (Table 4). The Lipid Lowering and Onset of 
Renal Disease (LORD) trial42 baseline data suggested underreporting was responsible for the 
low levels of nutrient intake. However, we consider our results close to the true intake as our 
patients were more advanced in age (65.7±13.6 vs. 60.0±15.0 years) and in later stages of 
23 
CKD (GFR 17.3±6.5 vs. 40.3±19.4 mL/min/1.73m2) compared to those in the LORD study, 
and also had high symptom burden. 
 
Obesity and diabetes in CKD stages 2–5 are strongly associated with hypovitaminosis D;61 
our cohort showed a high prevalence of obesity and suboptimal vitamin D intake, thus their 
vitamin D status was likely to be poor. Consumption of the core foods such as fruit and 
vegetables, the key contributors of antioxidants, phytochemicals, folates and dietary fibre, 
were poor in a large number of our patients. Thus, these patients were likely to have elevated 
levels of oxidative stress due to inadequate consumption of these nutrients and antioxidants.62 
It was challenging to identify the duration and reason of such suboptimal intake, if these were 
a result of uraemia and/or long-term poor eating habits similar to that reported in a national 
health survey in the general population.63  An adequate fruit and vegetable consumption is 
recommended as it has an alkali-inducing effect that is comparable to sodium bicarbonate in 
decreasing markers of kidney injury.64, 65 A high dietary fibre intake has also been associated 
with reduced risk of inflammation and mortality in patients with CKD.66, 67  Moreover, the 
promising  results  of  a  prospective  randomised  study  with  a  Mediterranean  diet  further 
convince healthy eating to improve dyslipidaemia, markers of inflammation and lipid 
peroxidation in stages 1–3 CKD patients.68 Data collection for vitamin and mineral 
supplementation was incomplete for discussion. While some of these supplements are 
necessary to correct certain clinical conditions in ESKD, they cannot replace optimal intake 
of adequate energy, essential nutrients and food components from diet. 
 
 
The majority of our patients were on a “free” diet prior to the initial clinic visit and presented 
with parameters indicative of poor nutritional health. The possible cause was a combination 
of advancing age, presence of uraemia and other symptoms, poor eating habits and self- 
induced inappropriate diet regimens. It is a common stigma in the renal community that 
dietary intervention in CKD implies restriction, which could cause malnutrition. Based on the 
24 
evidence from the literature and results of the current study, for CKD patients to stay on a 
“free” diet or “free” from nutrition intervention is unlikely to achieve optimal nutrition; 
worse, this may even cause a missing diagnosis of malnutrition and “self-induced” nutrition 
abnormality in these patients. All these factors are known to have carry-on effects after 





Nutrition requirements are indeed altered in ESKD and change over time. Although there is 
much debate about the timing of initiation and type of nutrition intervention in ESKD, 
before all the answers from high level of evidence are available, it appears logical to 
incorporate “healthy eating” explicitly with renal nutrition guidelines and recommendations 




The main limitation of our study was the lack of data on inflammatory markers, such as CRP, 
which is known to be closely associated with malnutrition and is a marker of CVD.9  It is 
worth noting that CRP did not associate with low fat stores, which in fact reflects poor EI.69 
 
Once again, this supports optimal EI being needed for optimal body composition. Other 
 
limitations were the lack of measure of urinary protein appearance for estimating dietary 
 
protein intake, as well as trace elements and antioxidants to verify the respective intakes as 
 




In summary, this pre-dialysis assessment clinic provided a platform to identify patients at 
nutritional risk and to initiate nutrition intervention irrespective of future choice of dialysis or 
conservative care programs. The results of this study also point to the needs for earlier 
structured intervention to prevent and to manage the complex nutritional abnormalities found 
in people with ESKD. Further studies are needed to gauge how to effectively implement the 







Patients presented to the current pre-dialysis assessment clinic with a high prevalence of 
abnormal nutrition parameters, including under- (malnutrition) and over-nutrition (overweight 
and obesity), compounded with a dietary intake of undesirable quality and quantity, either 






There is a high prevalence of nutritional abnormalities in pre-dialysis ESKD patients. The 
pre-dialysis assessment clinic provides a platform to assess the nutritional status of ESKD 
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Age >65 year (%) 64.3
Age >75 year (%) 28.1 
Gender (% male) 60.5 
Race (% Caucasian) 85.7 
Clinical and co-morbidities (%) 
GFR (mL/min/1.73m2), n =207 17.3±6.5
CKD stages 3:4:5 (%), n =207 5.3:56.5:3
8.2 
Smoking (% positive history), n =188 45.7 
Coronary artery disease (%) 34.8 
Diabetes mellitus (%) 35.2 
Peripheral vascular disease (%) 17.1
Cerebral vascular disease (%) 16.2 
Chronic lung disease (%) 10.5
Cause of ESKD 
Chronic glomerulonephritis (%) 16.7 
Diabetic nephropathy (%) 24.3 
Renovascular disease/ hypertensive nephrosclerosis (%) 21.4 
Adult polycystic kidney disease (%) 5.2 
Analgesic nephropathy (%) 4.8
IgA nephropathy (%) 9.5
Reflux nephropathy/congenital abnormality (%) 6.2
Other or unknown causes (%) 11.9
Table 2. Nutritional characteristics of patients attending the pre-dialysis assessment 
clinic 
 
Nutritional parameters (n missing) n = 210 
Anthropometry 
Weight (kg) 76.1±17.0 
Unintentional  weight  loss  (presence  of)  in  last  6
months (%) 
29.1 
Unintentional weight loss >5% in last 6 months (%) 8.1 
Unintentional  weight  loss  >5%  in  the  past  but 
stabilised 6 months before clinic (%) 
3.8 
Body mass index (kg/m2) 28.1±5.7 
BMI <23 kg/m2 (underweight) 17.1 
BMI >26 kg/m2 (overweight & obese) 62.4 
BMI >30 kg/m2 (obese) 31.4 
MAMC (cm) (n =14) 24.9±3.7 
MAMC % reference standard (%) (n =14) 97.8±14.1 
MAMC 10% < reference standard (%) (n =14) 28.6
TSF (mm) (n =14) 16.1±8.6
TSF % reference standard (n =14) 108.5±55.5
Biochemistry 
Serum creatinine (µmol/L) (n =1) 389.3±121.7 
Serum albumin (g/L) (n =1) 34.4±6.0 
Serum albumin below reference range (%) (n =1) 37.3 
Malnutrition score % 
SGA A:B:C (%) 59.5:36.7:3.8 
Malnourished (SGA B and C) 40.5
Malnourished + BMI >26 kg/m2 19.0
Malnourished + BMI >30 kg/m2 9.5
Table 3. Appetite score and presence of symptoms 
 
Appetite score: self-rated n =210 (%) 
(1) Very good 31.0 
(2) Good 39.0 
(3) Fair 23.3 
(4) Poor 5.7 
(5) Very poor 1.0 
Combined:  
(1)+(2) = Good appetite 70.0 
(3)+(4)+(5) = Reduced appetite 30.0 
Symptoms and behaviour (%) 
Presence of symptom (self-reported):
Nausea 
Taste aversion 




Presence of symptom (self-reported + prompting by dietitian 
during intake assessment) 
51.0 







Table 4. Dietary Intake of patients attending the pre-dialysis assessment clinic 
 
Energy/ nutrients/ foods (n 
=206 for protein and 











(or above if 
indicated) 
Energy (kcal/d) - 1575.2±240 - - 
Energy (kcal/kg IBW/d) 30 for >60 yr*‡ 
35 for <60 yr*‡ 
23.7±6.7 - 87.9 
>25†‡ - 62.6 
EI:REE >1.27 
(Goldberg cutoff)
1.06±0.27 - 42.7 
Protein (g/d) - 79.2±31.5 - - 
Protein (g/kg IWB/d) 0.75–1.00*‡ 1.18±0.42 119.0±51.3 13.1 (61.2 > 
recommendation) 
Protein (% energy) 15–20‡ 20.3±4.3 - - 
Fat (% energy) ~30‡ 31.7±7.5 - - 
Carbohydrate (% energy) ~50‡ 46.8±8.7 - - 
Alcohol (% energy) - 1.2±3.5 - - 
Monounsaturated fat (% 
total fat) 
~45‡ 42.5±8.2 - - 
Polyunsaturated fat (% total 
fat) 
~45‡ 22.9±8.8 - - 
Saturated fat (% total fat) <7§ 34.7±10.3 - - 
Thiamine, Vit. B1 (mg) 1.1–1.2
¶
 1.6±1.2 137.6±99.7 36.8 
Riboflavin Vit. B2 (mg) 0.9–1.6
¶
 1.7±1.4 132.5±112.9 41.2 
Niacin (mg) 14–16¶ 44.7±26.6 280.8±120.1 1.0 
Folate (µg) 400¶ 395.1±356.3 98.8±89.1 67.6 
Vitamin A (µg) 700–900¶ 890.4±553.7 108.4±67.0 52.9 
Vitamin C (mg) 45¶ 100.3±72.6 222.6±160.4 22.1 
Vitamin D (µg) 5.0 (19–50yr)¶ 
10–15 (>50 yr)¶ 
3.1±2.5 31.8±33.6 100.0 
Vitamin E (mg) 7–10¶ 8.2±4.0 94.1±45.5 61.8 
Calcium (mg) 1000–1300¶ 543.4±277.5 47.8±27.5 96.6 
Phosphorous (mg) 1000 ¶ 1136.4±441.2 114.0±43.5 40.7 
Iodine (µg) 150¶ 77.7±44.6 52.6±29.7 94.6 
Iron (mg) 8¶ 
18 for female 
(19–50yr) ¶ 
10.46±5.6 120.1±47.9 36.3 
Magnesium (mg) 310–400¶ 247.8±83.8 65.2±20.5 94.1 
Phosphorous (mg) 1000‡ 1129.2±458.3 116.8±78.6 41.6 
Zinc (mg) 8–14¶ 11.2±9.0 90.6±39.3 64.2 
Dietary fibre (g/d) 25–30¶ 21.4±8.4 76.0±29.3 80.4 
Fruit (serves/d) 2** 2.0±1.5 101.7±70.0 41.3 
Vegetable (serves/d) 5** 2.8±1.5 54.75±29.7 89.2 
Fish (g/d) 30g§ 33.6±52.5 110.7±175.0 60.8 
* K/DOQI guidelines40 
† PEW classification21 
‡ Evidence-based practice guidelines for the nutritional management of chronic kidney disease20 
§ American Heart Association38 
¶ NH&MRC nutrient reference values for the general Australian population 41 
** Go for 2 fruit & 5 vegetables™ campaign37 
Table 5. Demographic, clinical and nutritional parameters in different GFR ranges 
 
GFR (mL/min/1.73m2) 













8.4±1.4 12.5±1.4 17.4±1.4 25.1±5.7 n/a 





437.6±79* 361.2±72*† 297.5±71.0*†‡ <0.0001 
s-alb (g/L) 30.4±6.6 34.9±6.2* 34.0±6.4 35.7±4.4* 0.006 
s-alb below reference 
range (%) 
65 38.7 39.1 24.1 0.01 
BMI (kg/m2) 22.7±2.9 26.1±4.3 29.0±4.9*† 30.8±6.7*† <0.0001 
MAMC (% of standard) 
(n =14) 
87.7±8.4 95.1±13.2 99.4±13.5* 103.0±15.4*† <0.0001 
TSF (% of standard) 
(n =14) 
68.0±24.9 95.0±47.1 118.0±53.5* 126.4±64.9*† <0.0001 
Malnourished, SGA score 
B and C (%) 
 
80.0 48.4 29.0 31.0 
<0.0001 
Presence of symptom (%) 75.0 56.5 45.0 43.1 0.05 
Energy (kcal/kg IBW/d) 
(n =15) 
21.6±8.5 23.0±6.0 23.64±6.6 25.10±6.8 0.18 
Protein (g/kg IBW/d) 
(n =15) 
0.95±0.37 1.08±0.34 1.24±0.46* 1.31±0.44*† 0.001 
Abbreviation: GFR = glomerular filtration rate; s-alb = serum albumin; BMI = body mass index; 
MAMC  =  mid-arm  muscle  circumference;  TSF  =  triceps  skinfold;  SGA  =  subjective  global 
assessment 
For the continuous variables: 
* P <0.05 as compared with the GFR <10 mL/min/1.73m2 group 
† P <0.05 as compared with the GFR =10–15 mL/min/1.73m2 group 
‡ P <0.05 as compared with the GFR =15–20 mL/min/1.73m2 group 
 
Table  6.  Demographic, clinical  and  nutritional  parameters  across  different  age 
categories 
 
Age group (year) 









Age (year) 50.6±10.4 70.3±3.0* 79.1±3.0*† <0.0001 
GFR (mL/min/1.73m2) 20.3±6.8 16.7±4.8* 13.5±4.9*† <0.0001 





s-alb (g/L) 35.4±6.9 36.0±5.5 35.7±3.4 0.85 
s-alb < reference range (%) 29.7 37.7 46.4 0.14 
BMI (kg/m2) 28.4±6.9 29.3±4.9 26.0±5.7*† 0.003 
MAMC (% of standard) 
(n =14) 
100.6±16.2 98.7±12.7 93.5±12.2* 0.02 
TSF (% of standard) 
(n =14) 
108.7±55.4 117.7±54.4 95.8±55.6 0.08 
Malnourished, SGA score B 
or C (%) 
 
21.3 48.1 55.2 
<0.0001 
Presence of symptom (%) 32.0 66.2 55.2 <0.0001 
Energy (kcal/kg IBW/d) 
(n =4) 
27.9±6.8 21.2±5.9* 21.8±4.9* <0.0001 
Protein (g/kg IBW/d) 
(n =4) 
1.44±0.44 1.07±0.39* 1.01±0.43* <0.0001 
Abbreviation: GFR = glomerular filtration rate; s-alb = serum albumin; BMI = body mass 
index; MAMC = mid-arm muscle circumference; TSF = triceps skinfold; SGA = subjective 
global assessment 
For the continuous variables: 
* P <0.05 as compared with the age <65 year group 


















































▲ Denotes patients with self-imposed inappropriate intake 
 








































▲ Denotes patients with self-imposed inappropriate intake 
 
--- Denotes 0.75g/kg IBW/d to 1.0g/kg IBW/d of protein 

































---  Denotes 25kcal/kg IBW/d of energy 
































---  Denotes 0.75g/kg IBW/d to 1.0g/kg IBW/d of protein 
